Streetbeat News

Stock Prices

ETRN

OKE

WMB

The most accurate Wall Street analysts recommend buying three high-yielding energy stocks: ONEOK, Inc. (OKE), Equitrans Midstream Corporation (ETRN), and The Williams Companies, Inc. (WMB). These stocks have dividend yields of 5.90%, 6.30%, and 5.32% respectively. Recent news for these companies includes better-than-expected Q2 earnings for OKE and WMB, and a change in leadership for ETRN.

Portfolio Pulse from Lisa Levin

September 11, 2023 | 12:32 pm

BLRX

The FDA has approved BioLineRx's Aphexda plus filgrastim for use in mobilizing hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in multiple myeloma patients. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:32 pm

AVTA

Avantax has entered into a definitive agreement to be acquired by Cetera Holdings for $26 per share in cash.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 12:31 pm

SGMA

SigmaTron International's shares are trading lower following the release of its Q1 FY24 earnings.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:28 pm

TNON

Tenon Medical has announced a proposed public offering of common stock, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:27 pm

AEP

CHDN

DKNG

VZ

Jim Cramer, on CNBC’s 'Mad Money Lightning Round,' recommended buying American Electric Power Company, Inc. (AEP) and DraftKings Inc. (DKNG), while expressing skepticism about Churchill Downs Incorporated (CHDN). He also mentioned that Verizon Communications Inc. (VZ) has an 8% yield and increased its dividend.

Portfolio Pulse from Priya Nigam

September 11, 2023 | 12:27 pm

FCEL

FuelCell Energy Inc (FCEL) reported a 41% YoY decline in Q3 FY23 revenue to $25.51 million, missing the consensus of $27.72 million. The decline was due to lower product revenues and lack of module sales. The company's EPS loss improved to $(0.06) from $(0.08) in 3Q22, beating the consensus. Operating loss expanded to $(41.1) million from $(28) million a year ago. FCEL held cash and equivalents of $413.9 million as of July 31, 2023. The company's backlog decreased by ~17.2% to $1.06 billion.

Portfolio Pulse from Akanksha Bakshi

September 11, 2023 | 12:26 pm

NBY

Novabay Pharmaceuticals has granted Biostem Technologies the right to commercialize Amniotic Tissue Allograft, a product intended for use as a protective covering during the repair of ocular surfaces. This has led to a rise in Novabay's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:24 pm

IBRX

ImmunityBio has secured $470 million in equity and debt financing from its founder, Dr. Patrick Soon-Shiong, and Nant entities. This has led to a rise in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:24 pm

TWNK

J.M. Smucker has announced its plans to acquire Hostess Brands, leading to a rise in Hostess Brands' shares.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 12:20 pm